Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Browse the complete record of transactions filed by Telman Deborah H, Director. Officer active across 3 companies, notably AtriCure, Inc.. Cumulatively, 28 reports have been recorded. History available since 15 June 2021. The latest transaction was disclosed on 12 November 2025 (Levée d'options). Regulator: SEC (Form 4). All data is openly available.
Companies and markets linked to Telman Deborah H
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Telman Deborah H is an administrateur, with 28 filings in total. Among the sampled recent filings, the most common transaction type is option exercise, and the observed period runs from 2021-06-17 to 2025-11-13. The companies mentioned are Gilead Sciences, INC., AtriCure, Inc. and Organon & Co., and the stated buy and sell amounts are EUR 0.